Further, a novel CHOP activator LGH00168 exhibited anti-tumor activity in A549 cells and mice bearing lung tumor xenografts via ROS-mediated loss of ∆ψM, ER stress, NF-κβ inhibition, and RIPK1-dependent necroptosis [290]. Here, RIPK1 is linked to neoplasm.